Journal Article

Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development

Sanda Sturlan, Georg Oberhuber, Britta G. Beinhauer, Brigitte Tichy, Sonja Kappel, Jacob Wang and Michael A. Rogy

in Carcinogenesis

Volume 22, issue 4, pages 665-671
Published in print April 2001 | ISSN: 0143-3334
Published online April 2001 | e-ISSN: 1460-2180 | DOI:
Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics


Show Summary Details


Interleukin-10-deficient mice develop colitis and colorectal cancer similar to the inflammatory bowel disease associated cancer in humans. The aim of this study was to identify possible mutations of oncogenes and tumour suppressor genes involved in tumorigenesis in Interleukin-10 (IL-10)-deficient mice. Twenty colon carcinomas from IL-10-deficient mice were screened for mutations in the K-ras and p53 genes by `cold' single-strand-conformation polymorphism. Immunohistochemical staining was performed to detect mutations in the proteins P53, APC and MSH2, and the transforming growth factor β type II receptor. Microsatellite instability was analysed at eight chromosomal loci and plasma levels of transforming growth factor β1 (TGF-β1) were also measured. At 9 weeks, 14% of the animals developed colorectal cancer, and at 10–31 weeks the incidence of carcinoma was 65%. No mutations were detected in the analysed oncogene and tumour suppressor genes. Plasma TGF-β1 levels in IL-10-deficient mice 10–31 weeks old were higher than in wild-type littermates e.g. 45.7 ± 4.6 ng/ml versus 19.8 ± 4.5 ng/ml (P < 0.01). No alterations in K-ras, p53, Apc and Msh2 genes suggests that other genes are involved in the development of these tumours. Elevated TGF-β1 plasma levels correspond to the high incidence of dysplasia and cancer. Normal expression of the TGF-β II receptors hints at genetic alterations in other members of the TGF-β receptor signal transduction pathway.

Keywords: APC, adenomatous polyposis coli; FAP, familial adenomatous polyposis; HNPCC, hereditary nonpolyposis colorectal cancer; IBD, inflammatory bowel disease; MMR, mismatch repair; PCR, polymerase chain reaction; SPF, specific-pathogen free; SSCP, single-strand conformation polymorphism; TGF-β, transforming growth factor β.

Journal Article.  5858 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.